From Discovery Science to the Clinic- Heritable Endocrine Cancers and Related Disorders
Professor Charis Eng (17 January 1962 – 13 August 2024) was Editor-in-Chief of Endocrine-Related Cancer from 2011 to 2021. Professor Eng was a recognised world leader in establishing basic cancer mechanisms, clinical implications and the potential of future therapeutic approaches across a broad spectrum of endocrine cancers, as well as being known for her mentorship and support of junior investigators.
In celebration of her research achievements and contributions to the study of endocrine cancer, the journal is now calling for contributions to this thematic collection, ‘From Discovery Science to the Clinic – Heritable Endocrine Cancers and Related Disorders’.
This collection is open for the submission of review, mini-review, and original research articles covering all fields in which Professor Eng published, including but not limited to, discovery and translational science in endocrine-related cancer genomics and genetics, as well as specifically precision medicine.
Collaborators and past mentees of Professor Eng are particularly encouraged to contribute submissions, as well as researchers at all career stages, including junior investigators, working in the fields in which she published.
If you would like to submit your article to be considered for publication in this collection, please email us with your proposed title and submission date to erc@bioscientifica.com prior to submission. Please include up to two paragraphs outlining the topic, the paper type, and how this submission relates to work published by Professor Eng during her career.
An example of this might be a paper that reviews or reports new data on one of the numerous endocrine-related cancer genes, including PTEN, SDHB/C/D and RET, where Professor Eng’s work made substantial impact.
Collection Editors
|
Associate Professor Joanne Ngeow Genomic Medicine, Lee Kong Chian School of Medicine, Nanyang Technological University, and Senior Consultant, Division of Medical Oncology at the National Cancer Centre, Singapore. Dr Ngeow currently heads the Cancer Genetics Service at the National Cancer Centre Singapore with an academic interest in hereditary cancer syndromes and translational clinical cancer genetics. Dr Ngeow is funded by the National Medical Research Council and Ministry of Health Singapore to explore how gene-environmental interactions predisposes to cancer initiation and progression and the implementation of genomics into routine clinical care in Asia. She has active studies understanding the genetic basis of thyroid, breast and endometrial cancers, as well as soft tissue sarcomas. |
|
|
Professor Deborah J Marsh Medical Science, and Head, Translational Oncology Group, University of Technology Sydney, Sydney, Australia. Professor Marsh’s primary research interests are in the fields of women’s cancers and familial endocrine cancers in general. In the context of endocrine disorders, over her career she has published extensively on PTEN-, CDC73- and RET-related conditions. Her research today in ovarian cancer is focussed on studying epigenomic aberrations, genetic engineering, drug target discovery and drug repurposing. |
 |
Professor Lois Mulligan Cancer Research Institute at Queen’s University, Kingston, Canada. Professor Mulligan's research focuses broadly on regulation of cellular processes that contribute to neuroendocrine tumour growth and spread. Primary interests include intracellular protein localization and trafficking, mechanisms of cell motility and invasive spread, and regulation of receptor signalling in neuroendocrine cell models. |
